Skip to main content

Crocs (CROX) Is Undervalued and a Prospective Investment

The stock performance of Crocs (CROX) was good in 2023. However, CROX shares experienced a decline of -16.5% in the last year. This decline is not seen as a negative sentiment but rather an opportunity to acquire CROX shares at a low price. The decrease in CROX stock makes it undervalued at the moment, as its performance remains solid in 2023. Despite the drop in CROX stock in 2023, in the long term, CROX shares have remained in an uptrend with an increase of +290% in the last 5 years. Here is an overview of CROX stock and why it is worth investing in.

1. Solid Performance

In the third quarter of 2023, CROX recorded a revenue growth of 15.04%, from $2.61 billion to $3 billion. In Q3 2023, its EPS also increased from $6.51 to $8.65, a 32.87% year-on-year increase. This improvement indicates that CROX is capable of growing rapidly in 2023. Since 2019, CROX has shown an average annual revenue increase of 44.3% and an EPS increase of an average of 100% per year. While CROCS' performance has slowed down, it remains solid and experiences double-digit growth in both top-line and bottom-line aspects in 2023.

2. Low Valuation

Despite its good performance, CROX stock is currently one of the stocks with a cheap valuation. At $102, CROX shares have a trailing P/E ratio of 11.7 and a P/B ratio of 5.11, which is relatively low compared to its performance. With CROX's performance rapidly improving in 2023, and assuming a full-year EPS value of 11.8, CROX shares have a forward P/E ratio of only 8.6, which means it is very cheap for an apparel stock with a well-known brand and solid performance.

Conclusion

The decline in CROX stock does not make it a bad investment; on the contrary, it makes CROX stock undervalued and attractive for investment. Over the past 3 years, CROX's performance has consistently improved, and with a low P/E ratio, CROX has the potential to increase if its performance continues to grow in 2024

Comments

Popular posts from this blog

Symbotic (SYM) Strong Growth and Undervalue in Q2 2025

In the rapidly evolving landscape of warehouse automation, Symbotic Inc. (NASDAQ: SYM) has emerged as a prominent player, delivering innovative AI-powered robotics solutions to major retailers. Despite recent stock volatility, the company's robust financial performance and strategic partnerships suggest significant growth potential. This article delves into Symbotic's recent earnings, stock performance, valuation, growth prospects, and associated risks to the company.

Oscar Health Stock (OSCR) Great Growth and Undervalue in Q1 2025

Oscar Health Inc. (NYSE: OSCR) has emerged as a notable player in the health insurance sector, leveraging technology to enhance healthcare accessibility and affordability. Despite facing challenges since its IPO, the company's recent financial performance indicates a promising turnaround. This article delves into Oscar Health's background, financial performance, stock valuation, growth prospects, and associated risks, providing a comprehensive overview for potential investors.

Meta Platforms Stock (META) Strong Growth and Good Value (Q1 2025 Earnings)

Meta Platforms Inc. (NASDAQ: META), the parent company of Facebook, Instagram, and WhatsApp, has demonstrated robust financial performance in the first quarter of 2025. With significant year-over-year growth in revenue and earnings, coupled with strategic investments in artificial intelligence (AI) and augmented reality (AR), Meta continues to solidify its position as a leader in the tech industry. This article provides an in-depth analysis of Meta's recent financial results, stock performance, growth prospects, and potential risks, offering insights for investors considering META stock.​